Insider · CIK 0001900772

Burns James William

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001900772

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Performance share unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−3,000 sh	—	—	9,000
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Chief Legal Officer	AAward	+3,000 sh	—	—	3,000
2026-04-02	AGIOAGIOS PHARMACEUTICALS, INC. · Performance share unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−8,500 sh	—	—	8,500
2026-04-02	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+8,500 sh	—	—	52,586
2026-04-02	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−3,280 sh	$34.71	−$114K	49,306
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+3,920 sh	—	—	45,249
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−1,187 sh	$28.96	−$34.4K	41,329
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+4,000 sh	—	—	42,516
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−1,681 sh	$28.96	−$48.7K	38,516
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+5,666 sh	—	—	40,197
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−1,187 sh	$28.96	−$34.4K	34,531
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+4,000 sh	—	—	35,718
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−3,920 sh	—	—	7,839
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−4,000 sh	—	—	8,000
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−5,666 sh	—	—	5,667
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−4,000 sh	—	—	0
2026-03-02	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−1,163 sh	$28.96	−$33.7K	44,086
2026-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Chief Legal Officer	AAward	+14K sh	—	—	14,000
2026-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Chief Legal Officer	AAward	+52K sh	—	—	52,000
2025-12-30	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+6,000 sh	—	—	34,650
2025-12-30	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−2,932 sh	$27.09	−$79.4K	31,718
2025-12-30	AGIOAGIOS PHARMACEUTICALS, INC. · Performance share unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−6,000 sh	—	—	0
2025-06-24	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−2,799 sh	$33.54	−$93.9K	28,650
2025-06-24	AGIOAGIOS PHARMACEUTICALS, INC. · Performance share unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−6,000 sh	—	—	6,000
2025-06-24	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+6,000 sh	—	—	31,449
2025-03-03	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−1,137 sh	$35.54	−$40.4K	18,650
2025-03-03	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−1,187 sh	$35.54	−$42.2K	21,463
2025-03-03	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−1,681 sh	$35.54	−$59.7K	25,449
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Chief Legal Officer	AAward	+12K sh	—	—	12,000
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+3,833 sh	—	—	19,787
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+4,000 sh	—	—	22,650
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+5,667 sh	—	—	27,130
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Chief Legal Officer	AAward	+11.8K sh	—	—	11,759
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Chief Legal Officer	AAward	+43.5K sh	—	—	43,500
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−3,833 sh	—	—	0
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−4,000 sh	—	—	4,000
2025-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−5,667 sh	—	—	11,333
2024-11-07	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−13.4K sh	$52.00	−$697K	24,041
2024-11-07	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−8,341 sh	$52.56	−$438K	15,700
2024-03-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−1,349 sh	$32.57	−$43.9K	37,169
2024-03-05	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−1,293 sh	$32.57	−$42.1K	34,518
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−3,834 sh	—	—	3,833
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+3,834 sh	—	—	35,811
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+4,000 sh	—	—	38,518
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Chief Legal Officer	AAward	+17K sh	—	—	17,000
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Chief Legal Officer	AAward	+60K sh	—	—	60,000
2024-03-01	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−4,000 sh	—	—	8,000
2024-02-14	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Chief Legal Officer	SSale	−545 sh	$25.14	−$13.7K	31,666
2024-02-12	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	+1,833 sh	—	—	32,211
2024-02-12	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Chief Legal Officer	MExercise/Conversion	−1,833 sh	—	—	0

Recent filings

Accepted (ET)
Jun 234
Burns James William0001439222-26-000087
SEC(opens sec.gov)
Apr 64
Burns James William0001439222-26-000067
SEC(opens sec.gov)
Mar 34
Burns James William0001439222-26-000042
SEC(opens sec.gov)
Jan 24
Burns James William0001439222-26-000010
SEC(opens sec.gov)

Companies

AGIOS PHARMACEUTICALS, INC.Chief Legal OfficerAGIO

Address

88 SIDNEY STREET

CAMBRIDGE, MA, 02139